Cape Investment Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23	Closed	-$1.37K	–	335
2025 Q4	$1.37K	Hold	23	–	–	﹤0.01%	1153
2025 Q3	$1.25K	Sell	23 -4	-15%	-$229	﹤0.01%	725
2025 Q2	$1.48K	Sell	27 -2	-7%	-$118	﹤0.01%	989
2025 Q1	$2.05K	Buy	29 +27	+1,350%	+$1.82K	﹤0.01%	889
2024 Q4	$131	Sell	2 -40	-95%	-$2.68K	﹤0.01%	1073
2024 Q3	$2.95K	Hold	42	–	–	﹤0.01%	784
2024 Q2	$3.46K	Sell	42 -136	-76%	-$11.3K	﹤0.01%	729
2024 Q1	$15.5K	Hold	178	–	–	0.01%	473
2023 Q4	$17.2K	Buy	178 +20	+13%	+$1.77K	0.01%	565
2023 Q3	$14K	Hold	158	–	–	0.01%	508
2023 Q2	$13.7K	Buy	158 +55	+53%	+$5.18K	0.01%	498
2023 Q1	$10K	Buy	+103	New	+$10.7K	0.01%	540